Elicio Therapeutics, Inc.
Ticker: 1601485
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2022 | Q1 FY2022 | Q1 FY2022 | Q3 FY2021 | Q3 FY2021 | Q2 FY2021 | Q1 FY2021 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 0.65-60.6% | 1.65+0.0% | 1.65+13.0% | 1.46+0.0% | 1.46+170.4% | 0.54+45.9% | 0.37 |
| Total Income | 0.65-60.6% | 1.65+0.0% | 1.65+13.0% | 1.46+0.0% | 1.46+170.4% | 0.54+45.9% | 0.37 |
| EXPENSES | |||||||
| Expenditure | 9.69-39.9% | 16.13+0.0% | 16.13-6.3% | 17.22+0.0% | 17.22-8.3% | 18.78-7.5% | 20.31 |
| Tax | — | — | — | — | 0.00 | 0.00 | 0.00 |
| PROFIT | |||||||
| Net Profit | -9.14+35.8% | -14.24+0.0% | -14.24+9.3% | -15.70+0.0% | -15.70+8.0% | -17.07+53.5% | -36.69 |
| KEY METRICS | |||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.30+37.5% | -0.48+0.0% | -0.48+9.4% | -0.53+0.0% | -0.53+8.6% | -0.58+62.8% | -1.56 |
Corporate Events
No corporate events found.